GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have become powerful tools for treating type 2 diabetes and obesity
The combination of GLP-1, GIP, and glucagon receptor agonism may further enhance these effects by collectively reducing the hepatic fat burden and systemic inflammatory state, thereby indirectly inhibiting the progression of fibrosis (47)
Disclaimer: This information is based on FDA-approved prescribing information and is for educational purposes only
These symptoms can be uncomfortable and may deter individuals from continuing the medication
Rival drugmaker Eli Lilly, whose pill secured FDA approval in only 50 days, sells its weight loss injectable Zepbound for about $299 to $449 a month, The Wall Street Journal added
Semaglutide therapy is a carefully managed process that should be overseen by a qualified healthcare professional, such as our experts at Beyond Stem Cells